Sarepta Therapeutics Stock Forecast

Stock Price Forecast

According to 24 analysts polled by S&P Global, Sarepta Therapeutics stock has a consensus rating of "Hold" and an average price target of $21.64. The average 1-year stock price forecast is 22.05% higher than the current stock price, while the lowest is $5.00 (-71.80%) and the highest is $38 (+114.33%).

Price Target: $21.64 (+22.05%)

Analyst Consensus: Hold

Price Target

Chart

Target	Low	Average	Median	High
Price	$5.00	$21.64	$20	$38
Change	-71.80%	+22.05%	+12.80%	+114.33%

Analyst Ratings

The average analyst rating for Sarepta Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	7	7	8	8	7	7
Buy	0	0	0	0	0	0
Hold	13	13	11	11	12	12
Sell	2	2	2	2	2	2
Strong Sell	3	3	3	3	3	3
Total	25	25	24	24	24	24

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ritu Baral TD Cowen	TD Cowen	Hold Maintains $17	Hold	Maintains	$17	-4.12%	Oct 21, 2026
Biren Amin Piper Sandler	Piper Sandler	Hold Maintains $20	Hold	Maintains	$20	+12.80%	Oct 19, 2026
Mitchell Kapoor H.C. Wainwright	H.C. Wainwright	Sell Reiterates $5	Sell	Reiterates	$5	-71.80%	Oct 19, 2026
Yun Zhong Wedbush	Wedbush	Buy Maintains $35	Buy	Maintains	$35	+97.41%	Oct 16, 2026
Unknown Analyst Leerink Partners No rating	Leerink Partners	Hold Reiterates $20	Hold	Reiterates	$20	+12.80%	Oct 15, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.83B

from 2.20B

-16.60%

from 2.20B

Revenue Next Year

1.38B

from 1.83B

-24.69%

from 1.83B

EPS This Year

4.32

from -5.05

EPS Next Year

2.40

from 4.32

-44.40%

from 4.32

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	701.89M	933.01M	1.24B	1.90B	2.20B	1.83B
Revenue Growth	29.96%	32.93%	33.26%	52.97%	15.58%	-16.60%
Operating Income	-443.61M	-536.20M	-267.82M	218.08M	-657.77M	418.05M
Net Income	-418.78M	-703.49M	-535.98M	235.24M	-713.41M	339.06M
EPS	-	-	-	-	-5.05	4.32
Forward PE	-	-	-	15.47	90.12	4.11
Free Cash Flow	-	-	-	-	-307.45M	147.00M
No. Analysts	-	-	-	-	-	20

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	1.9B
Avg	1.8B
Low	1.8B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-12.9%
Avg	-16.6%
Low	-18.9%

EPS Forecast

Chart

EPS	2026	2027	2028
High	5.86
Avg	4.32
Low	2.88

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-